We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.00 | 4.60% | 22.75 | 22.00 | 23.50 | 23.25 | 21.75 | 21.75 | 479,757 | 14:22:55 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 8.01 | 19.83M |
Date | Subject | Author | Discuss |
---|---|---|---|
16/7/2018 08:33 | Probably the most sensible post we will read for a long time. | monkeywench1 | |
16/7/2018 08:25 | After waiting for several years today I finally started to buy | montynj | |
16/7/2018 08:21 | It'll become of interest, technically, once 81 pence is reached & maintained. As with any other share where longterm resistance is breached. GLA. | dogwalker | |
16/7/2018 08:14 | Top up for me 6830 at 78.70 | pglancy | |
16/7/2018 08:14 | Nice start to the week, more to come I suspect. | rafboy | |
16/7/2018 08:11 | Managed to top up my spreadbet at 77p as I boarded the plane! | nobbygnome | |
15/7/2018 22:36 | Just a thought, but I wonder if any of this confidence will cross over to SBTX bearing in mind that the skin trials could be starting at the end of next month and now might be a good time to jump on board before there is any price rise. | wreckage | |
15/7/2018 20:40 | Cheers Parob... | someuwin | |
15/7/2018 20:02 | I am on a flight to Brussels tomorrow morning so will miss the fun (assuming there is some!). My flight is not until 8:25 so I should be able to just about add to my Spreadbet first thing though 😜..... | nobbygnome | |
15/7/2018 19:12 | Thanks elrico & Colin. At least you both add something. | paulhoodwinked | |
15/7/2018 19:12 | I did something I never thought I would today. After I saw Parob's excellent post, listing the bonkers range of tie-ups SoH has already forged with all these international companies, I couldn't help myself. I was soo excited, I showed the post to my wife, to give her some measure of Why I'm so excited about Opti and our prospects. Bear in mind, this is the special lady who forgave me for losing many many thousands when I was so passionate about Bioprogress!! What an extraordinary time we are living in, and a part of. John | 2350220 | |
15/7/2018 18:56 | Great ramping chaps well done. | monkeywench1 | |
15/7/2018 18:49 | He was at that presentation Steve O'Hara did last week so I can only imagine he quizzed SOH there and liked what he heard. To be fair he's a smart guy and anyone with their eyes open can see what is going on here. Would be great to have a name like Nigel Wray on the shareholder list! Can't wait for the open tomorrow. | colinzeal | |
15/7/2018 18:49 | It appears a number of people have got this as a strong indication from the investor presentation last week. He was heard saying he likes OPTI, was already invested in the 2nd company at the IP. Later at the end he seemed to be saying he has had a "chat with SOH" AND from this, it would appear the inference is he may invest in OPTI because it ticks the boxes he likes. Like I said, it is just a rumour, but one I like. There is much more afoot, IMHO. I'm sure it will all come out in the wash. | elrico | |
15/7/2018 18:38 | Elrico Where's the Nigel wray rumour come from? First I'd heard of it but seems several hnw and funds now want in. Been a long patient wait but starting to feel very smug.... S | shrewdmole | |
15/7/2018 18:36 | Paul - It all depends on the level of interest and price the interested parties are will to part with their cash. I'm not going to temp fate above what I have already done. I have since update this with a link, which makes for interesting reading. $Billion cosmetic business with a handful of staff more than OPTI. KJ cosmetic products partnered out. Not a clue who Kylie Jenner is. Darren of share price makes a very interesting comparison between SOH and KJ. | elrico | |
15/7/2018 18:14 | elrico according to your blog you are looking to see 'mid 80s' broken soon? Days or weeks? I like the update, links to parobs tweet and the links to pertinent articles. Nice touch. | paulhoodwinked | |
15/7/2018 17:14 | OPTI one to watch this week | elrico | |
15/7/2018 16:37 | #OPTI - @OptiBiotix partner @CII_Inc will be promoting @slimbiome at #IFT2018 from today until Wednesday. #MICROBIOMEhTtps://m | parob | |
15/7/2018 15:47 | I'm well aware of the board's thoughts on him but even if it results in the slightest increase in share price tomorrow I'll be happy - I'm here to make money not to go over old points, old bean. Like it or not, he has a large reach. | colinzeal | |
15/7/2018 15:33 | Colin, i thought we established Tw has no influence over Opti due to his past transgressions and more recently incorrectly identifying the wrong Mr Mcgeever after elrico corrected him. Bang bang bang. lol | paulhoodwinked | |
15/7/2018 13:55 | Haha! Hopefully there are a few who don't have access to HSR! | colinzeal | |
15/7/2018 13:11 | I'll shoot you down Colin as it's the HSR article from a few days ago just redone on SP,bang bang 😁 | scotty1 | |
15/7/2018 13:06 | Don't shoot me but there's another "Strong Buy" article on ShareProphets now. Hopefully that will lead to more buying tomorrow. | colinzeal | |
15/7/2018 12:59 | A recap of current and future revenue streams confirmed by RNS so far:- GoFigure- Sacco- HLH BioPharma Vertriebs GmbH - Nutrilinia- Pharmabiota- Galenicum Special Ingredients - Knighton Foods- Cereal Ingredients Inc.- Fine Foods & Pharmaceuticals- Trigen Pharma- Cambridge Commodities - Akums Drugs and Pharma- Seed Health- Morley's - Alfasigma- Unnamed global corporate ($100B+ turnover) for SweetBiotix manufacturing & distribution.Revenue not confirmed by RNS yet:- Tata X 2 (Slimbiome and LPGOS)- Mystery US Slimbiome customer | parob |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions